The market was valued at $18.5 billion in 2011 and reached $19 billion in 2012.
The report also estimates 30 percent of all healthcare products currently under develop are combination devices with built-in pharmaceutical or biologic components.
Combination devices include orthopedic applications, coronary stents, photodynamic therapies and antimicrobial catheters.
More Articles on Devices:
Alphatec Spine Receives FDA Clearance for 2 Cervical, Fixation Devices
Zimmer Recall Labeled High Risk by FDA
Orthopedic Device Company DJO Global Acquires Exos Corp
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
